Literature DB >> 24917952

Treatment of GORD: Three decades of progress and disappointments.

Jean Paul Galmiche1, Frank Zerbib2, Stanislas Bruley des Varannes1.   

Abstract

The treatment of GORD has been revolutionized by the introduction, in the 1980s, of proton-pump inhibitors as the mainstay of medical therapy and by the development of laparoscopic antireflux surgery which has definitively replaced open surgery. However, despite these major advances, many unmet therapeutic needs still persist and justify novel therapeutic approaches. The aim of this historical review is to recall the main discoveries in the treatment of GORD that have occurred during the last three decades and to discuss why some initially promising drugs or techniques have not translated into clinical applications. A careful analysis of these previous disappointing experiences should help to identify high priorities and better research programmes on the management of GORD.

Keywords:  GORD; laparoscopic anti-reflux surgery; proton-pump inhibitors; refractory reflux symptoms; transient lower oesophageal sphincter relaxations

Year:  2013        PMID: 24917952      PMCID: PMC4040757          DOI: 10.1177/2050640613484021

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  76 in total

1.  Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease.

Authors:  Guy E Boeckxstaens; Hanneke Beaumont; Veerle Mertens; Hans Denison; Magnus Ruth; John Adler; Debra G Silberg; Daniel Sifrim
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

Review 2.  Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.

Authors:  Daniel Sifrim; Frank Zerbib
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

3.  Esophageal pH monitoring on PPI therapy: removing the blinders.

Authors:  Radu Tutuian; Inder Mainie; Donald O Castell
Journal:  Am J Gastroenterol       Date:  2005-08       Impact factor: 10.864

4.  Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease.

Authors:  Thierry Piche; Stanislas Bruley des Varannes; Sylvie Sacher-Huvelin; Jens Juul Holst; Jean Claude Cuber; Jean Paul Galmiche
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

5.  Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Authors:  I Mainie; R Tutuian; A Agrawal; D Adams; D O Castell
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

6.  Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study.

Authors:  Nikos Viazis; Anastasia Keyoglou; Alexandros K Kanellopoulos; George Karamanolis; John Vlachogiannakos; Konstantinos Triantafyllou; Spiros D Ladas; Dimitrios G Karamanolis
Journal:  Am J Gastroenterol       Date:  2011-05-31       Impact factor: 10.864

7.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

Review 8.  Therapy of gastroesophageal reflux: evidence-based approach to antireflux surgery.

Authors:  Lars Lundell
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

9.  A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.

Authors:  Peter J Kahrilas; John Dent; Karsten Lauritsen; Peter Malfertheiner; Hans Denison; Stefan Franzén; Goran Hasselgren
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10-22       Impact factor: 11.382

10.  A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease.

Authors:  C Keywood; M Wakefield; J Tack
Journal:  Gut       Date:  2009-05-20       Impact factor: 23.059

View more
  5 in total

1.  Gastro-oesophageal reflux disease: illness or illusion?

Authors:  A Pali S Hungin
Journal:  Br J Gen Pract       Date:  2015-08       Impact factor: 5.386

2.  (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.

Authors:  Joshua S Niedzielski; Jinzhong Yang; Zhongxing Liao; Daniel R Gomez; Francesco Stingo; Radhe Mohan; Mary K Martel; Tina M Briere; Laurence E Court
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-21       Impact factor: 7.038

Review 3.  Modern diagnosis of GERD: the Lyon Consensus.

Authors:  C Prakash Gyawali; Peter J Kahrilas; Edoardo Savarino; Frank Zerbib; Francois Mion; André J P M Smout; Michael Vaezi; Daniel Sifrim; Mark R Fox; Marcelo F Vela; Radu Tutuian; Jan Tack; Albert J Bredenoord; John Pandolfino; Sabine Roman
Journal:  Gut       Date:  2018-02-03       Impact factor: 23.059

Review 4.  Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.

Authors:  A Pali S Hungin; Michael Molloy-Bland; Carmelo Scarpignato
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

5.  A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial.

Authors:  Kamran Bagheri Lankarani; Gholam Reza Sivandzadeh; Marziyeh Zare; Mohammadali Nejati; Ramin Niknam; Ali Reza Taghavi; Fardad Ejtehadi; Mahvash Alizade Naini; Maryam Moini; Mohammad Hossein Anbardar; Payam Peymani
Journal:  Acta Biomed       Date:  2020-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.